Researchers Study Nasal Administration of Bionor Pharma's Therapeutic HIV Vaccine Vacc-4x Combined With Eurocine Vaccines' Endocine(TM) in Fully Enrolled Trial; New Treatment Option Would Offer Easier Treatment Access for HIV Patients Globally
04 janv. 2012 08h00 HE | Bionor Pharma
OSLO, NORWAY--(Marketwire - Jan 4, 2012) - News Summary Bionor Pharma's Vacc-4x is an investigational therapeutic HIV vaccine that has already shown in a...